Floatz logo

[177Lu]Lu-A9-0631

GRPR-positive Solid Tumors

Alpha-9 Oncology USA Inc.Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the GRPR-positive Solid Tumors cohort.

Asset / SponsorPhaseRating
[225Ac]Ac-A9-0642
Alpha-9 Oncology USA Inc.
Phase 1CC

Same molecule, other indications

[177Lu]Lu-A9-0631 is also rated in:

breast cancerDormant
C
Indicative ·
36 / 100
View asset →
prostate cancerDormant
C
Indicative ·
36 / 100
View asset →
colorectal cancerDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →